REQUEST A DEMO
Total
USD $0.00
Search more companies

Macrogen Inc. (South Korea)

Main Activities: Research and Development in Nanotechnology
Full name: Macrogen Inc. Profile Updated: June 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

MACROGEN INC is a biotechnology company that specializes in genomic analysis. Its offerings include next-generation sequencing (NGS), bioinformatics, gene synthesis, and clinical diagnostics, focusing on cancer genomics, personalized medicine, and microbiome research. MACROGEN INC claims to serve over 18,000 research institutions across 153 countries.

Headquarters
10F Word Merdian Venture Center, 60-24 Gasan-Dong, Geumcheon-Gu
Seoul; Seoul; Postal Code: 153-801

Contact Details: Purchase the Macrogen Inc. report to view the information.

Website: http://www.macrogen.com

Basic Information
Total Employees:
Purchase the Macrogen Inc. report to view the information.
Outstanding Shares:
Purchase the Macrogen Inc. report to view the information.
Registered Capital:
Purchase the Macrogen Inc. report to view the information.
Financial Auditors:
Purchase the Macrogen Inc. report to view the information.
Incorporation Date:
June 05, 1997
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
8.74%
Purchase this report to view the information.
0.87%
Purchase this report to view the information.
0.77%
Purchase this report to view the information.
0.25%
Purchase this report to view the information.
0.15%
Subsidiaries
㈜마크로젠
Company Performance
Financial values in the chart are available after Macrogen Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
46.63%
Total operating revenue
51.21%
Operating Profit/Loss (EBIT)
75.21%
EBITDA
N/A
Net Profit/Loss for the Period
60.75%
Total Assets
24.59%
Total Equity
12.71%
Operating Profit Margin (ROS)
7.28%
Net Profit Margin
6.59%
Return on Equity (ROE)
3.72%
Debt/Equity
10.25%
Quick Ratio
0.1%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?